Literature DB >> 25404026

Chemical biology applied to the study of bacterial pathogens.

Rebecca Anthouard1, Victor J DiRita2.   

Abstract

In recent years, chemical biology and chemical genomics have been increasingly applied to the field of microbiology to uncover new potential therapeutics as well as to probe virulence mechanisms in pathogens. The approach offers some clear advantages, as identified compounds (i) can serve as a proof of principle for the applicability of drugs to specific targets; (ii) can serve as conditional effectors to explore the function of their targets in vitro and in vivo; (iii) can be used to modulate gene expression in otherwise genetically intractable organisms; and (iv) can be tailored to a narrow or broad range of bacteria. This review highlights recent examples from the literature to illustrate how the use of small molecules has advanced discovery of novel potential treatments and has been applied to explore biological mechanisms underlying pathogenicity. We also use these examples to discuss practical considerations that are key to establishing a screening or discovery program. Finally, we discuss the advantages and challenges of different approaches and the methods that are emerging to address these challenges.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Mesh:

Substances:

Year:  2014        PMID: 25404026      PMCID: PMC4294262          DOI: 10.1128/IAI.02021-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  102 in total

Review 1.  Chemistry-based functional proteomics for drug target deconvolution.

Authors:  Kui Wang; Tao Yang; Qian Wu; Xia Zhao; Edouard Collins Nice; Canhua Huang
Journal:  Expert Rev Proteomics       Date:  2012-06       Impact factor: 3.940

2.  Novel inhibitors of bacterial virulence: development of 5,6-dihydrobenzo[h]quinazolin-4(3H)-ones for the inhibition of group A streptococcal streptokinase expression.

Authors:  Bryan D Yestrepsky; Yuanxi Xu; Meghan E Breen; Xiaoqin Li; Walajapet G Rajeswaran; Jenny G Ryu; Roderick J Sorenson; Yasuhiro Tsume; Michael W Wilson; Wenpeng Zhang; Duxin Sun; Hongmin Sun; Scott D Larsen
Journal:  Bioorg Med Chem       Date:  2013-02-01       Impact factor: 3.641

Review 3.  Optimizing the balance between host and environmental survival skills: lessons learned from Listeria monocytogenes.

Authors:  Bobbi Xayarath; Nancy E Freitag
Journal:  Future Microbiol       Date:  2012-07       Impact factor: 3.165

4.  Fluoro-phenyl-styrene-sulfonamide, a novel inhibitor of σB activity, prevents the activation of σB by environmental and energy stresses in Bacillus subtilis.

Authors:  Daina L Ringus; Ahmed Gaballa; John D Helmann; Martin Wiedmann; Kathryn J Boor
Journal:  J Bacteriol       Date:  2013-03-22       Impact factor: 3.490

5.  Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets.

Authors:  Martin L Miller; Evan J Molinelli; Jayasree S Nair; Tahir Sheikh; Rita Samy; Xiaohong Jing; Qin He; Anil Korkut; Aimee M Crago; Samuel Singer; Gary K Schwartz; Chris Sander
Journal:  Sci Signal       Date:  2013-09-24       Impact factor: 8.192

Review 6.  Target identification and mechanism of action in chemical biology and drug discovery.

Authors:  Monica Schenone; Vlado Dančík; Bridget K Wagner; Paul A Clemons
Journal:  Nat Chem Biol       Date:  2013-04       Impact factor: 15.040

7.  Evidence for sigma factor competition in the regulation of alginate production by Pseudomonas aeruginosa.

Authors:  Yeshi Yin; T Ryan Withers; Xin Wang; Hongwei D Yu
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

8.  Novel inhibitors of Staphylococcus aureus virulence gene expression and biofilm formation.

Authors:  Yibao Ma; Yuanxi Xu; Bryan D Yestrepsky; Roderick J Sorenson; Meng Chen; Scott D Larsen; Hongmin Sun
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

9.  Small-molecule inhibitors of toxT expression in Vibrio cholerae.

Authors:  Rebecca Anthouard; Victor J DiRita
Journal:  mBio       Date:  2013-08-06       Impact factor: 7.867

10.  Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis.

Authors:  Thomas R Ioerger; Theresa O'Malley; Reiling Liao; Kristine M Guinn; Mark J Hickey; Nilofar Mohaideen; Kenan C Murphy; Helena I M Boshoff; Valerie Mizrahi; Eric J Rubin; Christopher M Sassetti; Clifton E Barry; David R Sherman; Tanya Parish; James C Sacchettini
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

View more
  7 in total

1.  Narrow-spectrum inhibitors of Campylobacter jejuni flagellar expression and growth.

Authors:  Jeremiah G Johnson; Caroline Yuhas; Thomas J McQuade; Martha J Larsen; Victor J DiRita
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

2.  Inhibition of Protein Secretion in Escherichia coli and Sub-MIC Effects of Arylomycin Antibiotics.

Authors:  Shawn I Walsh; David S Peters; Peter A Smith; Arryn Craney; Melissa M Dix; Benjamin F Cravatt; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

3.  Structure-Guided Identification of a Small Molecule That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria.

Authors:  Marina Orman; Smaranda Bodea; Michael A Funk; Ana Martínez-Del Campo; Maud Bollenbach; Catherine L Drennan; Emily P Balskus
Journal:  J Am Chem Soc       Date:  2018-12-17       Impact factor: 15.419

4.  Not just an antibiotic target: Exploring the role of type I signal peptidase in bacterial virulence.

Authors:  Shawn I Walsh; Arryn Craney; Floyd E Romesberg
Journal:  Bioorg Med Chem       Date:  2016-09-21       Impact factor: 3.641

Review 5.  Small Molecules That Sabotage Bacterial Virulence.

Authors:  Benjamin K Johnson; Robert B Abramovitch
Journal:  Trends Pharmacol Sci       Date:  2017-02-14       Impact factor: 14.819

6.  Coalition of Biology and Chemistry for Ameliorating Antimicrobial Drug Discovery.

Authors:  Dipesh Dhakal; Jae Kyung Sohng
Journal:  Front Microbiol       Date:  2017-05-04       Impact factor: 5.640

Review 7.  Narrowing the spectrum: the new frontier of precision antimicrobials.

Authors:  Alexandra E Paharik; Henry L Schreiber; Caitlin N Spaulding; Karen W Dodson; Scott J Hultgren
Journal:  Genome Med       Date:  2017-12-14       Impact factor: 11.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.